Comparison

CCG 203769 European Partner

Item no. TMO-T10705-1mg
Manufacturer TargetMol
CASRN 410074-60-1
Amount 1mg
Category
Type Inhibitor
Specific against other
Purity 0,98
Smiles O=C1SN(C(=O)N1CCCC)CC
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Thiadiazolidinone (TDZD) deriv. 6 , 4-butyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione , RGS4 inhibitor 11b
Available
Short Description
CCG 203769 is a selective inhibitor of RGS4 with an IC50 of 17 nM for the RGS4-Gαo protein-protein interaction.
Shipping
cool pack
Storage
-20°
Target names or alias
Thiadiazolidinone (TDZD) deriv. 6 , 4-butyl-2-ethyl-1, 2, 4-thiadiazolidine-3, 5-dione , RGS4 inhibitor 11b
Molecular Weight
202, 27
Pathway
GPCR/G Protein|||Stem Cells|||PI3K/Akt/mTOR signaling|||Neuroscience
Target
GSK-3|||Dopamine Receptor|||GTPase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close